RHHBF — Stock activity · TradeandTellRHHB
RHHBF
$443.68-$12.20 (-2.68%)live
Held by
0
portfolios on TandT
Avg position size
—
of holders' portfolios
52-week range
$301.27 – $514.08
67% from low
Held by traders on TradeandTell
No one on the platform currently holds RHHBF.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in RHHBF as of their last filing.
Insider activity (SEC Form 4)
Dividend history
TTM yield · 6.78% ($30.10/share)
| Ex-date | Per share | Pay date |
|---|
| 2026-03-13 | $0.9990 | 2026-03-16 |
| 2026-03-13 | $9.8000 | 2026-03-16 |
| 2025-03-28 | $9.7000 | 2025-03-31 |
| 2024-03-14 | $9.6000 | 2024-03-18 |
Recent trades on TradeandTell
No one on the platform has traded RHHBF yet.
Insider activity (SEC Form 4)
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Analyst estimates (consensus)
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|
| 2026 | $61.9B | +0.1% | $19.85 | $19.26–$21.08 | 22.3× | 1 |
| 2027 | $64.5B | +4.2% | $21.42 | $20.79–$22.74 | 20.7× | 1 |
| 2028 | $67.6B | +4.8% | $23.20 | $22.51–$24.63 | 19.1× | 1 |
| 2029 | $71.1B | +5.3% | $25.75 | $24.99–$27.34 | 17.2× | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Earnings surprises
Beat consensus in 0 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|
| 2026-01-29 | $10.83 | $10.56 | -2.5% |
| 2025-07-24 | $13.18 | $5.81 | -55.9% |
| 2025-01-30 | $9.25 | $2.77 | -70.1% |
| 2024-10-23 | $10.42 | $8.71 | -16.4% |
| 2024-04-26 | $10.07 | $6.34 | -37.0% |
| 2023-11-29 | $11.62 | $9.90 | -14.8% |
| 2023-02-02 | $9.49 | $5.26 | -44.6% |
| 2022-07-21 | $11.53 |
DCF fair valuemodel estimate
Peer comparison
| Symbol | Price | Today | Mkt cap | P/E |
|---|
| RHHBFRoche Holding AG | $443.68 | -2.68% | $353.5B | — |
| AZNCFAstraZeneca PLC | $189.90 | -1.35% | $294.4B | — |
| CHGCFChugai Pharmaceutical Co., Ltd. | $43.22 | -0.84% | $71.1B | — |
| CHGCYChugai Pharmaceutical Co., Ltd. | $21.61 | -3.61% | $71.1B | — |
| DSKYFDaiichi Sankyo Company, Limited | $16.41 |
| DSNKYDaiichi Sankyo Company, Limited | $17.18 | -1.83% | $31.3B | — |
| GLAXFGSK plc | $25.42 | +0.91% | $101.9B | — |
Source: Financial Modeling Prep · peers by sector/industry